Optimized production and concentration of lentiviral vectors containing large inserts

被引:104
作者
Al Yacoub, Nadya [1 ]
Romanowska, Malgorzata [1 ]
Haritonova, Natalie [1 ]
Foerster, John [1 ]
机构
[1] Charite, Dept Dermatol, Berlin, Germany
关键词
lentivirus; ultracentrifugation; titer; virus production;
D O I
10.1002/jgm.1052
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Generation of high titer lentiviral stocks and efficient virus concentration are central to maximize the utility of lentiviral technology. Here we evaluate published protocols for lentivirus production on a range of transfer vectors differing in size (7.5-13.2 kb). We present a modified virus production protocol robustly yielding useful titers (Up to 10(7)/ml) for a range of different transfer vectors containing packaging inserts up to 7.5 kb. Moreover, we find that virus recovery after concentration by ultracentrifugation depends on the size of the packaged inserts, heavily decreasing for large packaged inserts. We describe a fast (4 h) centrifugation protocol at reduced speed allowing high virus recovery even for large and fragile lentivirus vectors. The protocols outlined in the current report should be useful for many labs interested in producing and concentrating high titer lentiviral stocks. Copyright (C) 2007 John Wiley & Sons, Ltd.
引用
收藏
页码:579 / 584
页数:6
相关论文
共 27 条
[1]   Gene therapy of storage disorders by retroviral and lentiviral vectors [J].
Biffi, A ;
Naldini, L .
HUMAN GENE THERAPY, 2005, 16 (10) :1133-1142
[2]   Lentiviral and MLV based retroviral vectors for ex vivo and in vivo gene transfer [J].
Blesch, A .
METHODS, 2004, 33 (02) :164-172
[3]   A trans-lentiviral packaging cell line for high-titer conditional self-inactivating HIV-1 vectors [J].
Cockrell, Adam S. ;
Ma, Hong ;
Fu, Kailing ;
McCown, Thomas J. ;
Kafri, Tal .
MOLECULAR THERAPY, 2006, 14 (02) :276-284
[4]   A third-generation lentivirus vector with a conditional packaging system [J].
Dull, T ;
Zufferey, R ;
Kelly, M ;
Mandel, RJ ;
Nguyen, M ;
Trono, D ;
Naldini, L .
JOURNAL OF VIROLOGY, 1998, 72 (11) :8463-8471
[5]   A new-generation stable inducible packaging cell line for lentiviral vectors [J].
Farson, D ;
Witt, R ;
McGuinness, R ;
Dull, T ;
Kelly, M ;
Song, JP ;
Radeke, R ;
Bukovsky, A ;
Consiglio, A ;
Naldini, L .
HUMAN GENE THERAPY, 2001, 12 (08) :981-997
[6]   Lentiviral transgene vectors -: Green light for efficient production of transgenic farm animals [J].
Fässler, R .
EMBO REPORTS, 2004, 5 (01) :28-29
[7]   Transactivator and structurally optimized inducible lentiviral vectors [J].
Haack, K ;
Cockrell, AS ;
Ma, H ;
Israeli, D ;
Steffan, NH ;
McCown, TJ ;
Kafri, T .
MOLECULAR THERAPY, 2004, 10 (03) :585-596
[8]   Comparison of transfection conditions for a lentivirus vector produced in large volumes [J].
Karolewski, BA ;
Watson, DJ ;
Parente, MK ;
Wolfe, JH .
HUMAN GENE THERAPY, 2003, 14 (14) :1287-1296
[9]   A stable system for the high-titer production of multiply attenuated lentiviral vectors [J].
Klages, N ;
Zufferey, R ;
Trono, D .
MOLECULAR THERAPY, 2000, 2 (02) :170-176
[10]   Doxycycline-regulated lentiviral vector system with a novel reverse transactivator rtTA2S-M2 shows a tight control of gene expression in vitro and in vivo [J].
Koponen, JK ;
Kankkonen, H ;
Kannasto, J ;
Wirth, T ;
Hillen, W ;
Bujard, H ;
Ylä-Herttuala, S .
GENE THERAPY, 2003, 10 (06) :459-466